US4814434A
(en)
*
|
1984-02-03 |
1989-03-21 |
Ventres Laboratories, Inc. |
Inducer of T-suppressor cells
|
US5043267A
(en)
*
|
1984-05-18 |
1991-08-27 |
E. I. Du Pont De Nemours And Company |
Method for rapid detection of bacterial and fungal infection
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
US4843155A
(en)
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
US5077216A
(en)
|
1988-07-06 |
1991-12-31 |
The Trustees Of Dartmouth College |
Monoclonal antibodies specific for a human mononculear phagocyte-specific antigen
|
US5459039A
(en)
|
1989-05-12 |
1995-10-17 |
Duke University |
Methods for mapping genetic mutations
|
EP0552108B1
(en)
|
1992-01-17 |
1999-11-10 |
Lakowicz, Joseph R. |
Energy transfer phase-modulation fluoro-immunoassay
|
ATE267877T1
(en)
|
1993-01-07 |
2004-06-15 |
Sequenom Inc |
DNA SEQUENCING THROUGH MASS SPECTRONOMY
|
WO1994021686A1
(en)
|
1993-03-19 |
1994-09-29 |
Northern Sydney Area Health Service |
Papp-a, its immunodetection and uses
|
US5594637A
(en)
|
1993-05-26 |
1997-01-14 |
Base Ten Systems, Inc. |
System and method for assessing medical risk
|
US5498531A
(en)
|
1993-09-10 |
1996-03-12 |
President And Fellows Of Harvard College |
Intron-mediated recombinant techniques and reagents
|
US5514598A
(en)
|
1993-11-30 |
1996-05-07 |
Doody; Michael |
Prenatal detection of meconium
|
US6025395A
(en)
|
1994-04-15 |
2000-02-15 |
Duke University |
Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
|
US7625697B2
(en)
*
|
1994-06-17 |
2009-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for constructing subarrays and subarrays made thereby
|
US6117985A
(en)
*
|
1995-06-16 |
2000-09-12 |
Stemcell Technologies Inc. |
Antibody compositions for preparing enriched cell preparations
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
US6031088A
(en)
|
1996-05-23 |
2000-02-29 |
Albert Einstein College Of Medicine Of Yeshiva University |
Polycystic kidney disease PKD2 gene and uses thereof
|
US20030044859A1
(en)
|
1996-08-19 |
2003-03-06 |
Henslee Jerry G. |
Reagents and methods useful for detecting diseases of the breast
|
US20010051341A1
(en)
|
1997-03-04 |
2001-12-13 |
Isis Innovation Limited |
Non-invasive prenatal diagnosis
|
GB9704444D0
(en)
|
1997-03-04 |
1997-04-23 |
Isis Innovation |
Non-invasive prenatal diagnosis
|
US20020119118A1
(en)
|
1997-11-03 |
2002-08-29 |
Genentech, Inc. |
Novel polypeptides and nucleic acids encoding bolekine
|
JPH11118792A
(en)
*
|
1997-10-17 |
1999-04-30 |
Ajinomoto Co Inc |
Method for sorting macrophage, assay for immunological disease and screening method of remedy for immunological disease
|
JP3301963B2
(en)
*
|
1998-04-14 |
2002-07-15 |
和久 鍬田 |
Screening method for severe invasion
|
CA2359816C
(en)
|
1999-01-06 |
2010-08-03 |
Genenews Inc. |
Method for the detection of gene transcripts in blood and uses thereof
|
US6762032B1
(en)
|
1999-08-23 |
2004-07-13 |
Biocrystal, Ltd. |
Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
|
ATE439453T1
(en)
|
2000-06-05 |
2009-08-15 |
Genetics Inst Llc |
COMPOSITIONS, TEST SETS AND METHODS FOR IDENTIFYING AND MODULATING TYPE I DIABETES
|
ATE375404T1
(en)
|
2000-06-27 |
2007-10-15 |
Von Recklinghausen Ges E V |
METHOD FOR COLLECTING DATA FOR THE PRESYMPTOMATIC OR PRENATAL DIAGNOSIS OF TYPE 1 NEUROFIBROMATOSIS
|
US6631330B1
(en)
|
2000-08-21 |
2003-10-07 |
Assistance Publique-Hopitaux De Paris (Ap-Hp) |
Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
|
WO2002028999A2
(en)
*
|
2000-10-03 |
2002-04-11 |
Gene Logic, Inc. |
Gene expression profiles in granulocytic cells
|
US6664056B2
(en)
|
2000-10-17 |
2003-12-16 |
The Chinese University Of Hong Kong |
Non-invasive prenatal monitoring
|
AU2002258379A1
(en)
*
|
2000-10-24 |
2002-09-19 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
FR2816411B1
(en)
|
2000-11-03 |
2003-07-04 |
Inst Nat Sante Rech Med |
MEANS FOR DETECTING THE PATHOLOGICAL TRANSFORMATION OF THE APP PROTEIN AND THEIR APPLICATIONS
|
EP1351707B9
(en)
|
2001-01-09 |
2012-01-25 |
Baylor Research Institute |
Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
|
WO2002061434A2
(en)
|
2001-01-29 |
2002-08-08 |
The Center For Blood Research, Inc |
Anergy-regulated molecules
|
US6753137B2
(en)
|
2001-01-31 |
2004-06-22 |
The Chinese University Of Hong Kong |
Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma
|
GB0104690D0
(en)
|
2001-02-26 |
2001-04-11 |
Cytogenetic Dna Services Ltd |
Diagnostic test
|
FR2824144B1
(en)
|
2001-04-30 |
2004-09-17 |
Metagenex S A R L |
METHOD OF PRENATAL DIAGNOSIS ON FETAL CELLS ISOLATED FROM MATERNAL BLOOD
|
US7202044B2
(en)
|
2001-05-09 |
2007-04-10 |
Biovision Ag |
Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2003019193A1
(en)
|
2001-08-30 |
2003-03-06 |
Ciphergen Biosystems, Inc. |
Method of diagnosing nephrotic syndrome
|
US6927028B2
(en)
|
2001-08-31 |
2005-08-09 |
Chinese University Of Hong Kong |
Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
|
US20050130245A1
(en)
|
2001-09-17 |
2005-06-16 |
Syn X Pharma, Inc. |
Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins
|
US20040038201A1
(en)
*
|
2002-01-22 |
2004-02-26 |
Whitehead Institute For Biomedical Research |
Diagnostic and therapeutic applications for biomarkers of infection
|
US6986995B2
(en)
|
2002-02-28 |
2006-01-17 |
Prometheus Laboratories, Inc. |
Methods of diagnosing liver fibrosis
|
US7744876B2
(en)
|
2002-04-09 |
2010-06-29 |
The Curators Of The University Of Missouri |
Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes
|
US7009038B2
(en)
|
2002-05-02 |
2006-03-07 |
Univ. Of Medicine & Dentistry Of N.J. |
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
|
EP3072978B1
(en)
|
2002-05-09 |
2018-07-11 |
The Brigham and Women's Hospital, Inc. |
1l1rl-1 as a cardiovascular disease marker
|
US20040009518A1
(en)
|
2002-05-14 |
2004-01-15 |
The Chinese University Of Hong Kong |
Methods for evaluating a disease condition by nucleic acid detection and fractionation
|
US7157235B2
(en)
|
2002-06-17 |
2007-01-02 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
WO2004003548A1
(en)
*
|
2002-06-26 |
2004-01-08 |
Fischer Ag |
Method for the determination of characteristics and/or the classification of circulating macrophages, and analysis arrangement for carrying out said method
|
WO2004005921A1
(en)
|
2002-07-05 |
2004-01-15 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases
|
FR2844279A1
(en)
|
2002-09-06 |
2004-03-12 |
Inst Nat Sante Rech Med |
MEANS FOR DETECTING NEURODEGENERATIVE PROCESSES AND THEIR APPLICATIONS
|
US20040141969A1
(en)
|
2002-09-16 |
2004-07-22 |
Juergen Floege |
Method for the treatment of nephritis using anti-PDGF-DD antibodies
|
EP1714981A3
(en)
|
2002-10-02 |
2006-12-20 |
F.Hoffmann-La Roche Ag |
Method for the identification of antigenic peptides
|
EP1571970B1
(en)
|
2002-10-02 |
2011-08-17 |
DMI Biosciences, Inc. |
Diagnosis and monitoring of diseases
|
US20040086864A1
(en)
|
2002-10-22 |
2004-05-06 |
The Chinese University Of Hong Kong |
Novel classification methods for pleural effusions
|
GB0225360D0
(en)
|
2002-10-31 |
2002-12-11 |
Univ London |
Genetic markers
|
US8039218B2
(en)
*
|
2002-11-14 |
2011-10-18 |
John Wayne Cancer Institute |
Detection of cancer cells in body fluids
|
US7611839B2
(en)
*
|
2002-11-21 |
2009-11-03 |
Wyeth |
Methods for diagnosing RCC and other solid tumors
|
AU2002952993A0
(en)
|
2002-11-29 |
2002-12-12 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
Therapeutic and diagnostic agents
|
CN101260429B
(en)
|
2003-01-17 |
2011-03-30 |
香港中文大学 |
Circulating mRNA as diagnostic markers of pregnancy related disorders
|
US20060259991A1
(en)
|
2003-02-04 |
2006-11-16 |
Evotech Neurosciences Gmbh |
Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases
|
WO2004071269A2
(en)
|
2003-02-13 |
2004-08-26 |
Intellectual Property Consulting Inc. |
Gene marker and composition for diagnosis and treatment of neurological disorders and diseases and use of the same
|
WO2004076639A2
(en)
|
2003-02-26 |
2004-09-10 |
Wyeth |
Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
|
JP2006519616A
(en)
|
2003-03-03 |
2006-08-31 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ |
Tyrosine phosphatase-PRL-1, marker for pancreatic cancer and therapeutic target
|
US20070105105A1
(en)
*
|
2003-05-23 |
2007-05-10 |
Mount Sinai School Of Medicine Of New York University |
Surrogate cell gene expression signatures for evaluating the physical state of a subject
|
CA2529759A1
(en)
|
2003-06-20 |
2005-10-13 |
University Of Florida |
Biomarkers for differentiating between type 2 and type 2 diabetes
|
DE10333406A1
(en)
|
2003-07-15 |
2005-02-10 |
Protagen Ag |
T-regulatory cells containing galectins for the therapy and diagnosis of diseases
|
WO2005012907A1
(en)
|
2003-08-01 |
2005-02-10 |
Renovar, Inc. |
Systems and methods for characterizing kidney diseases
|
WO2005017192A2
(en)
|
2003-08-14 |
2005-02-24 |
The General Hospital Corporation |
Screening for gestational disorders
|
AU2004270220B2
(en)
|
2003-09-05 |
2009-03-05 |
The Chinese University Of Hong Kong |
Method for non-invasive prenatal diagnosis
|
US7445886B2
(en)
|
2003-09-10 |
2008-11-04 |
Board Of Regents, The University Of Texas System |
Macrophage migration inhibitory factor as a marker for cardiovascular risk
|
US20050181386A1
(en)
|
2003-09-23 |
2005-08-18 |
Cornelius Diamond |
Diagnostic markers of cardiovascular illness and methods of use thereof
|
CA2539535A1
(en)
|
2003-10-03 |
2005-04-14 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof
|
EP1689884A4
(en)
|
2003-10-08 |
2007-04-04 |
Univ Boston |
Methods for prenatal diagnosis of chromosomal abnormalities
|
ATE435301T1
(en)
|
2003-10-16 |
2009-07-15 |
Sequenom Inc |
NON-INVASIVE DETECTION OF FETAL GENETIC CHARACTERISTICS
|
US7670764B2
(en)
|
2003-10-24 |
2010-03-02 |
Prometheus Laboratories Inc. |
Methods of diagnosing tissue fibrosis
|
EP1685410A1
(en)
|
2003-11-19 |
2006-08-02 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
|
US20060094064A1
(en)
|
2003-11-19 |
2006-05-04 |
Sandip Ray |
Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
|
EP1692520A2
(en)
|
2003-11-19 |
2006-08-23 |
Satoris, Inc. |
Method for diagnosis, stratification and monitoring of alzheimer's disease
|
US7939634B2
(en)
|
2004-01-27 |
2011-05-10 |
Compugen Ltd. |
Polynucleotides encoding polypeptides and methods using same
|
EP1711633A1
(en)
|
2004-02-04 |
2006-10-18 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of the kcne4 gene and protein for alzheimer disease
|
US20050266432A1
(en)
|
2004-02-26 |
2005-12-01 |
Illumina, Inc. |
Haplotype markers for diagnosing susceptibility to immunological conditions
|
DE102004016437A1
(en)
*
|
2004-04-04 |
2005-10-20 |
Oligene Gmbh |
Method for detecting signatures in complex gene expression profiles
|
EP1733231B1
(en)
|
2004-04-05 |
2011-05-04 |
Université Bordeaux 2 |
Peptides and peptidomimetics binding to cd23
|
US20080051334A1
(en)
|
2004-04-16 |
2008-02-28 |
Evotec Neurosciences Gmbh |
Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases
|
ES2524309T3
(en)
|
2004-04-20 |
2014-12-05 |
Sphingotec Gmbh |
Use of tachykinin precursors and / or their fragments in medical diagnosis
|
AU2005240669A1
(en)
|
2004-05-07 |
2005-11-17 |
Garvan Institute Of Medical Research |
Detecting disease association with aberrant glycogen synthase kinase 3-beta expression
|
US20080038730A1
(en)
|
2004-05-10 |
2008-02-14 |
Heinz Von Der Kammer |
Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's Disease
|
WO2005114222A1
(en)
|
2004-05-13 |
2005-12-01 |
Sphingo Tec Gmbh |
Use of precursors of enkephalins and/or their fragments in medical diagnostics
|
WO2005113828A1
(en)
*
|
2004-05-14 |
2005-12-01 |
King Pharmaceuticals Research & Development, Inc. |
Methods of diagnosing and prognosticating solid tumors and melanoma
|
AU2005243064A1
(en)
|
2004-05-19 |
2005-11-24 |
Harold Wood Hospital |
ADAM12, a novel marker for abnormal cell function
|
US7709194B2
(en)
|
2004-06-04 |
2010-05-04 |
The Chinese University Of Hong Kong |
Marker for prenatal diagnosis and monitoring
|
CA2574727A1
(en)
|
2004-07-19 |
2006-02-23 |
University Of Rochester |
Biomarkers of neurodegenerative disease
|
AU2005280528B2
(en)
|
2004-07-30 |
2010-12-23 |
Adeza Biomedical Corporation |
Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
|
EP1789798A4
(en)
|
2004-08-13 |
2009-02-18 |
Xceed Molecular Corp |
Markers for autoimmune disease detection
|
US7833795B2
(en)
|
2004-08-24 |
2010-11-16 |
The Trustees Of The University Of Pennsylvania |
Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors
|
US20070087376A1
(en)
|
2004-08-30 |
2007-04-19 |
Potashkin Judith A |
Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases
|
US7595159B2
(en)
|
2004-11-03 |
2009-09-29 |
The Brigham And Women's Hospital, Inc. |
Prediction of Parkinson's disease using gene expression levels of peripheral blood samples
|
WO2006048778A1
(en)
|
2004-11-08 |
2006-05-11 |
King's College London |
Markers of predisposition to addictive states
|
US20060115854A1
(en)
|
2004-12-01 |
2006-06-01 |
Power3 Medical Products, Inc. |
Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease
|
US20060115855A1
(en)
|
2004-12-01 |
2006-06-01 |
Power3 Medical Products, Inc. |
FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease
|
GB0426859D0
(en)
|
2004-12-07 |
2005-01-12 |
Proteome Sciences Plc |
Diagnosis of neurodegenerative disorders
|
EP1825274B1
(en)
|
2004-12-07 |
2009-11-18 |
Electrophoretics Limited |
Monitoring Huntington's disease
|
CA2595112A1
(en)
|
2004-12-31 |
2006-07-13 |
Genentech, Inc. |
Polypeptides that bind br3 and uses thereof
|
FR2880897B1
(en)
|
2005-01-18 |
2010-12-17 |
Inst Nat Sante Rech Med |
METHOD OF DETECTION, NON-INVASIVE, PRENATAL, IN VITRO OF NORMAL HEALTHY CONDITION, HEALTHY CARRIER STATUS OR SICK CARRIER STATUS OF MUCOVISCIDOSIS
|
US7432107B2
(en)
|
2005-01-24 |
2008-10-07 |
Roche Diagnostics Operations, Inc. |
Cardiac hormones for assessing cardiovascular risk
|
CA2596518A1
(en)
|
2005-01-31 |
2006-08-10 |
Insilicos, Llc |
Methods of identification of biomarkers with mass spectrometry techniques
|
US7572592B2
(en)
|
2005-01-31 |
2009-08-11 |
Glycominds Ltd |
Method for diagnosing multiple sclerosis
|
US20070141625A1
(en)
|
2005-02-03 |
2007-06-21 |
Santos Jose H |
Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies
|
ITRM20050067A1
(en)
|
2005-02-17 |
2006-08-18 |
Istituto Naz Per Le Malattie I |
METHOD FOR THE DETECTION OF VIRAL OR VIRAL NUCLEIC ACIDS IN URINE.
|
CA2894337C
(en)
|
2005-03-18 |
2018-08-28 |
The Chinese University Of Hong Kong |
Markers for prenatal diagnosis of trisomy 18
|
CN101137760B
(en)
|
2005-03-18 |
2011-01-26 |
香港中文大学 |
Method for the detection of chromosomal aneuploidies
|
EP1866441A4
(en)
|
2005-03-24 |
2009-11-11 |
Beth Israel Hospital |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
DE602006014379D1
(en)
|
2005-04-06 |
2010-07-01 |
Klinik Und Poliklinik Fuer Psy |
NEURODEGENERATIVE MARKERS FOR DEPRESSION.
|
AU2006238475B2
(en)
|
2005-04-18 |
2012-09-27 |
Opsona Therapeutics Limited |
Toll-like receptor 14 (TLR14 ) and use thereof
|
WO2006114661A1
(en)
|
2005-04-26 |
2006-11-02 |
Dwek Raymond A |
High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
|
US7604948B2
(en)
|
2005-05-05 |
2009-10-20 |
The Regents Of The University Of California |
Biomarkers for diagnosing an autism spectrum disorder
|
WO2006125117A2
(en)
|
2005-05-18 |
2006-11-23 |
Novartis Ag |
Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
|
US20070015172A1
(en)
*
|
2005-06-01 |
2007-01-18 |
Z-Biomed, Inc. |
Expression profiles for microbial infection
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
WO2006135904A2
(en)
*
|
2005-06-13 |
2006-12-21 |
Kohne David E |
Method for producing improved results for applications which directly or indirectly utilize gene expression assay results
|
GB0512401D0
(en)
|
2005-06-17 |
2005-07-27 |
Randox Lab Ltd |
Method
|
GB2428240A
(en)
|
2005-07-14 |
2007-01-24 |
Univ Gen Ve |
Diagnostic method for brain damage-related disorders
|
US20070148661A1
(en)
|
2005-07-19 |
2007-06-28 |
Duke University |
LSAMP Gene Associated With Cardiovascular Disease
|
TW200712493A
(en)
|
2005-09-28 |
2007-04-01 |
Univ Nat Taiwan |
Tumor marker for ovarian cancer diagnosis
|
US20070218469A1
(en)
|
2005-10-03 |
2007-09-20 |
Ruth Navon |
Novel mutations in hexosaminidase A
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for diagnosis of preeclamsia
|
WO2007044860A2
(en)
|
2005-10-11 |
2007-04-19 |
Tethys Bioscience, Inc. |
Diabetes-associated markers and methods of use thereof
|
WO2007047907A2
(en)
|
2005-10-14 |
2007-04-26 |
The Regents Of The University Of Michigan |
Dek protein compositions and methods of using the same
|
TW200736260A
(en)
|
2005-11-10 |
2007-10-01 |
Smithkline Beecham Corp |
Inhibitors of Akt activity
|
PT2360479E
(en)
|
2005-12-22 |
2014-07-10 |
Baxter Healthcare Sa |
Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
|
TW200726845A
(en)
|
2006-01-02 |
2007-07-16 |
Nat Defense Medical Ct |
Biomarker molecular of renal illness and detecting method for the same
|
EP1808694A1
(en)
|
2006-01-17 |
2007-07-18 |
Universitätsklinikum Freiburg |
Method for diagnosing polycystic kidney disease
|
FR2896588B1
(en)
|
2006-01-20 |
2016-08-19 |
Univ D'angers |
METHOD OF IN VITRO DIAGNOSIS OF AUTOIMMUNE IMMUNE RESPONSE BY DETECTION OF ANTIBODIES AGAINST ANTIGEN PENTRAXIN 3.
|
EP1987361A4
(en)
|
2006-01-30 |
2009-03-04 |
Invitrogen Corp |
Compositions and methods for detecting and quantifying toxic substances in disease states
|
US7459280B2
(en)
|
2006-02-27 |
2008-12-02 |
Picobella, Llc |
Methods for diagnosing and treating kidney cancer
|
ATE535535T1
(en)
|
2006-02-28 |
2011-12-15 |
Phenomenome Discoveries Inc |
METHODS FOR DIAGNOSING DEMENTIA AND OTHER NEUROLOGICAL DISEASES
|
US7488584B2
(en)
|
2006-03-24 |
2009-02-10 |
Picobella |
Methods for diagnosing and treating kidney and colorectal cancer
|
US20070224638A1
(en)
|
2006-03-27 |
2007-09-27 |
Institut Pasteur |
Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
|
GB0606776D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Pharma Ag |
Predictive biomarkers for chronic allograft nephropathy
|
EP1847615A1
(en)
|
2006-04-18 |
2007-10-24 |
Genoscreen |
Expression and polymorphism of the ornithine transcarbamylase (OTC) gene as markers for diagnosing Alzheimer's disease
|
US7662578B2
(en)
|
2006-04-21 |
2010-02-16 |
Children's Hospital Medical Center |
Method and kit for the early detection of impaired renal status
|
ATE517341T1
(en)
|
2006-04-27 |
2011-08-15 |
Critical Care Diagnostics Inc |
INTERLEUKIN-33 (IL-33) FOR THE DIAGNOSIS AND PREDICTION OF CARDIOVASCULAR DISEASES
|
PL2482078T3
(en)
|
2006-05-01 |
2016-08-31 |
Critical Care Diagnostics Inc |
Diagnosis of cardiovascular disease
|
US7901884B2
(en)
|
2006-05-03 |
2011-03-08 |
The Chinese University Of Hong Kong |
Markers for prenatal diagnosis and monitoring
|
US7754428B2
(en)
|
2006-05-03 |
2010-07-13 |
The Chinese University Of Hong Kong |
Fetal methylation markers
|
US8257933B2
(en)
|
2006-05-12 |
2012-09-04 |
Keio University |
Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
|
WO2007131345A1
(en)
|
2006-05-12 |
2007-11-22 |
The Hospital For Sick Children |
Genetic risk factor in sod1 and sfrs15 in renal disease, diabetic cataract, cardiovascular disease and longevity
|
EP2548578B1
(en)
|
2006-05-17 |
2014-08-20 |
The Ludwig Institute for Cancer Research |
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
|
WO2007139895A2
(en)
|
2006-05-24 |
2007-12-06 |
Cellumen, Inc. |
Method for modeling a disease
|
US20080038269A1
(en)
|
2006-05-25 |
2008-02-14 |
Mount Sinai Hospital |
Methods for detecting and treating kidney disease
|
EP2030025A2
(en)
|
2006-06-07 |
2009-03-04 |
Tethys Bioscience, Inc. |
Markers associated with arteriovascular events and methods of use thereof
|
DE102006027818A1
(en)
|
2006-06-16 |
2007-12-20 |
B.R.A.H.M.S. Aktiengesellschaft |
In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative diseases
|
WO2008084331A2
(en)
|
2006-06-21 |
2008-07-17 |
Hopitaux Universitaires De Geneve |
Biomarkers for renal disorders
|
WO2008003826A1
(en)
|
2006-07-07 |
2008-01-10 |
Oy Jurilab Ltd |
Novel genes and markers in essential arterial hypertension
|
KR100856375B1
(en)
|
2006-07-18 |
2008-09-04 |
김현기 |
Marker for diagnosing Neurodegenerative diseases
|
US7851172B2
(en)
|
2006-07-25 |
2010-12-14 |
University Of Kentucky Research Foundation |
Biomarkers of mild cognitive impairment and alzheimer's disease
|
WO2008014516A2
(en)
|
2006-07-28 |
2008-01-31 |
Living Microsystems, Inc. |
Selection of cells using biomarkers
|
US20080026378A1
(en)
|
2006-07-28 |
2008-01-31 |
Gian Franco Bottazzo |
Prediction and prophylactic treatment of type 1 diabetes
|
ITTO20060614A1
(en)
|
2006-08-21 |
2008-02-22 |
Uni Degli Studi Del Piemonte |
"DIFFERENTIAL DIAGNOSIS FOR THE SCLERODERMIA"
|
US20080152589A1
(en)
|
2006-09-08 |
2008-06-26 |
Peter Schofield |
Diagnostics and Therapeutics of Neurological Disease
|
WO2008031917A1
(en)
|
2006-09-14 |
2008-03-20 |
Zora Biosciences Oy |
Biofluid metabolite profiling as a tool for early prediction of autoimmunity and type 1 diabetes risk
|
EP1905841A1
(en)
|
2006-09-25 |
2008-04-02 |
Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; |
Trex1 as a marker for lupus erythematosus
|
EP2067040A2
(en)
|
2006-09-26 |
2009-06-10 |
ProteoSys AG |
Use of at least one isoform of progesterone receptor membrane component 1 (pgrmc1)
|
WO2008042012A1
(en)
|
2006-10-05 |
2008-04-10 |
Rhode Island Hospital |
Compositions and methods for detecting and treating renal injury and inflammation
|
WO2008043725A1
(en)
|
2006-10-10 |
2008-04-17 |
Novartis Ag |
Biomarker in inflammatory disorders
|
US20100029007A1
(en)
|
2006-10-11 |
2010-02-04 |
Novaartis Ag |
Biomarker in Inflammatory Diseases
|
WO2008046512A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Schering Pharma Aktiengesellschaft |
Prss23 as a biomarker, therapeutic and diagnostic target
|
ES2443042T3
(en)
|
2006-10-16 |
2014-02-17 |
Bayer Intellectual Property Gmbh |
LTBP2 as a biomarker, therapeutic and diagnostic target
|
WO2008046510A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Healthcare Ag |
Fn1 as a biomarker, therapeutic and diagnostic target
|
US20100081136A1
(en)
|
2006-10-16 |
2010-04-01 |
Stefan Golz |
Crtac as a biomarker, therapeutic and diagnostic target
|
WO2008046160A1
(en)
|
2006-10-20 |
2008-04-24 |
Newcastle Innovation Limited |
Assay for the detection of biomarkers associated with pregnancy related conditions
|
CN101636175A
(en)
|
2006-11-01 |
2010-01-27 |
乔治梅森知识产权公司 |
The biomarker that is used for neurological conditions
|
JP2010510528A
(en)
|
2006-11-22 |
2010-04-02 |
ライフ テクノロジーズ コーポレーション |
Biomarkers for autoimmune diseases
|
US20100169988A1
(en)
|
2006-12-06 |
2010-07-01 |
Bernhard Kohli |
Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same
|
US20090104605A1
(en)
|
2006-12-14 |
2009-04-23 |
Gary Siuzdak |
Diagnosis of sepsis
|
IL180095A0
(en)
|
2006-12-14 |
2007-05-15 |
Ohad Birk |
Method for antenatal estimation of down syndrome risk
|
US8362224B2
(en)
|
2006-12-19 |
2013-01-29 |
The Trustees Of The University Of Pennsylvania |
Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases
|
US8815519B2
(en)
|
2006-12-22 |
2014-08-26 |
Hvidovre Hospital |
Method for predicting cancer and other diseases
|
ES2476842T3
(en)
|
2007-01-10 |
2014-07-15 |
Purdue Research Foundation |
HSP27 kinase polypeptide inhibitors and uses thereof
|
WO2008085024A1
(en)
|
2007-01-12 |
2008-07-17 |
Erasmus University Medical Center Rotterdam |
Identification and detection of peptides relating to specific disorders
|
EP2468888B1
(en)
|
2007-01-22 |
2018-04-11 |
Medizinische Universität Innsbruck |
Novel markers for chronic kidney disease
|
EP2115167A1
(en)
|
2007-02-08 |
2009-11-11 |
Powmri Limited |
Method of diagnosing a neurodegenerative disease
|
US20080261226A1
(en)
|
2007-02-15 |
2008-10-23 |
Rengang Wang |
Biomarkers of neurodegenerative disease
|
EP2471954B1
(en)
|
2007-02-21 |
2016-08-24 |
Decode Genetics EHF |
Genetic susceptibility variants associated with cardiovascular disease
|
US20080227709A1
(en)
|
2007-03-14 |
2008-09-18 |
Baylor Research Institute |
Gene expression in peripheral blood mononuclear cells from children with diabetes
|
US8101380B2
(en)
|
2007-03-26 |
2012-01-24 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs
|
EP1975252A1
(en)
|
2007-03-29 |
2008-10-01 |
INSERM (Institut National de la Santé et de la Recherche Medicale) |
Methods for the prognosis or for the diagnosis of a thyroid disease
|
US20120052592A9
(en)
|
2007-03-30 |
2012-03-01 |
Nano Solution, Inc., |
Method for determining prognosis of acute central nervous system disorder
|
EP2579038B1
(en)
|
2007-04-12 |
2014-10-01 |
Universiteit Hasselt |
Biomarkers for multiple sclerosis
|
GB0707933D0
(en)
|
2007-04-24 |
2007-05-30 |
Apitope Technology Bristol Ltd |
Disease markers
|
GB0708075D0
(en)
|
2007-04-26 |
2007-06-06 |
Univ Nottingham |
Nethods
|
JP5714326B2
(en)
|
2007-05-01 |
2015-05-07 |
ユニバーシティ オブ マイアミ |
Transcriptome biomarkers for individual risk assessment in newly ongoing heart failure
|
AU2008247398B2
(en)
|
2007-05-03 |
2013-10-10 |
Medimmune, Llc |
Interferon alpha-induced pharmacodynamic markers
|
WO2008147938A2
(en)
|
2007-05-24 |
2008-12-04 |
Centocor, Inc. |
Wnt5a as an inflammatory disease marker
|
WO2008154238A1
(en)
|
2007-06-06 |
2008-12-18 |
Siemens Healthcare Diagnostics Inc. |
Predictive diagnostics for kidney disease
|
CA2689131A1
(en)
|
2007-06-08 |
2008-12-11 |
Vib Vzw |
The novel adipocytokine visfatin/pbef1 is an apoptosis associated factor induced in monocytes during in vivo hiv-1 infection
|
WO2008156867A1
(en)
|
2007-06-21 |
2008-12-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarkers for the diagnosis of autoimmune disease
|
ITRM20070351A1
(en)
|
2007-06-22 |
2008-12-23 |
Istituto Naz Per Le Malattie I |
GENE CODIFYING AMBER PROTEIN 1 HAVING REGULATORY ACTIVITY OF THE SELF-FAILURE AND DEVELOPMENT OF THE CENTRAL NERVOUS SYSTEM
|
WO2009000520A1
(en)
|
2007-06-25 |
2008-12-31 |
Universität Duisburg-Essen |
Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders
|
US8227201B2
(en)
|
2007-06-27 |
2012-07-24 |
Board Of Trustees Of The Leland Stanford Junior University |
BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease
|
JP2010533866A
(en)
|
2007-07-13 |
2010-10-28 |
ジェネンテック, インコーポレイテッド |
Methods for treating and diagnosing cancer, inflammatory diseases and autoimmune diseases
|
EP2164977B1
(en)
|
2007-07-17 |
2013-10-30 |
Metabolon, Inc. |
Biomarkers for pre-diabetes and methods using the same
|
CN101815945A
(en)
|
2007-08-02 |
2010-08-25 |
Iss免疫系统刺激股份公司 |
Diagnosis, staging and monitoring of inflammatory bowel disease
|
US20090275046A1
(en)
|
2007-08-29 |
2009-11-05 |
Power3 Medical Products, Inc. |
Complement factor H protein as a biomarker of Parkinson's disease
|
WO2009032722A1
(en)
|
2007-08-29 |
2009-03-12 |
The Cleveland Clinic Foundation |
Carbamylated proteins and risk of cardiovascular disease
|
US8748100B2
(en)
|
2007-08-30 |
2014-06-10 |
The Chinese University Of Hong Kong |
Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences
|
GB0717637D0
(en)
|
2007-09-10 |
2007-10-17 |
Univ Leiden |
Future cardiac event biomarkers
|
US8062852B2
(en)
|
2007-10-01 |
2011-11-22 |
The Children's Hospital And Regional Medical Center |
Detection and treatment of autoimmune disorders
|
ITUD20070183A1
(en)
|
2007-10-01 |
2009-04-02 |
Univ Degli Studi Udine |
DIAGNOSTIC AND PROGNOSTIC METHOD FOR DIAGNOSIS AND PROGNOSIS OF LYMPHOPROLIFERATION IN AUTOIMMUNE DISEASES
|
US20100216119A1
(en)
|
2007-10-15 |
2010-08-26 |
King's College London |
Diagnostic Methods for HIV Infection
|
CA2703165A1
(en)
|
2007-10-22 |
2009-04-30 |
The Regents Of The University Of California |
Biomarkers for prenatal diagnosis of congenital cytomegalovirus
|
FI20070795A0
(en)
|
2007-10-24 |
2007-10-24 |
Faron Pharmaceuticals Oy |
A new biomarker for monitoring disease development and assessing the effectiveness of therapies
|
CN110376377A
(en)
|
2007-10-26 |
2019-10-25 |
拜奥希特公司 |
For diagnosing the method and product of the autoimmune disease and gastric cancer that are associated with atrophic gastritis
|
WO2009059259A2
(en)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Detection of worsening renal disease in subjects with systemic lupus erythematosus
|
WO2009058168A1
(en)
|
2007-11-04 |
2009-05-07 |
Prediction Sciences Llc |
Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
|
EP2209916B1
(en)
|
2007-11-08 |
2011-12-21 |
Novartis AG |
Gene expression signatures for chronic/sclerosing allograft nephropathy
|
WO2009065132A1
(en)
|
2007-11-16 |
2009-05-22 |
Oklahoma Medical Research Foundation |
Predicting and diagnosing patients with autoimmune disease
|
EP2245188A2
(en)
|
2007-11-28 |
2010-11-03 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Biomarkers for the onset of neurodegenerative diseases
|
US8506933B2
(en)
|
2007-11-30 |
2013-08-13 |
Msdx, Inc. |
Methods of detecting a neurological condition via analysis of circulating phagocytes
|
WO2009074331A2
(en)
|
2007-12-11 |
2009-06-18 |
Julius-Maximilians-Universität Würzburg |
Early and differential diagnosis test for alzheimer's disease
|
WO2009075566A1
(en)
|
2007-12-12 |
2009-06-18 |
Erasmus University Medical Center Rotterdam |
Biomarkers for cardiovascular disease
|
EP2075343A1
(en)
|
2007-12-21 |
2009-07-01 |
Gert Mayer |
A method of diagnosing a progressive disease
|
EP2240601B1
(en)
|
2007-12-27 |
2016-10-12 |
Compugen Ltd. |
Biomarkers for the prediction of renal injury
|
CA2712303C
(en)
|
2008-01-18 |
2015-03-31 |
President And Fellows Of Harvard College |
Methods of detecting signatures of disease or conditions in bodily fluids
|
CA2739944A1
(en)
|
2008-01-23 |
2009-07-30 |
Rigshospitalet |
Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40
|
US20090299155A1
(en)
|
2008-01-30 |
2009-12-03 |
Dexcom, Inc. |
Continuous cardiac marker sensor system
|
CN101983337A
(en)
|
2008-02-04 |
2011-03-02 |
班扬生物标记公司 |
Process to diagnose or treat brain injury
|
MX2010008698A
(en)
|
2008-02-08 |
2010-12-20 |
Medimmune Llc |
Disease markers and uses thereof.
|
US20090239242A1
(en)
|
2008-03-18 |
2009-09-24 |
Biotrin Intellectual Properties Limited |
Method for the early identification and prediction of kidney injury
|
CA2646040A1
(en)
|
2008-03-22 |
2009-09-22 |
David V. Pow |
Detection of a biomarker of aberrant cells of neuroectodermal origin in a body fluid
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
EP2107377A1
(en)
|
2008-04-04 |
2009-10-07 |
BRAHMS Aktiengesellschaft |
Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
|
WO2009122387A1
(en)
|
2008-04-04 |
2009-10-08 |
Biotrin Group Ltd. |
Method for the detection and prediction of obesity-related renal disease
|
EP2279270B1
(en)
|
2008-04-15 |
2014-06-18 |
Oberbauer, Rainer |
Markers of acute kidney failure
|
US8030097B2
(en)
|
2008-04-30 |
2011-10-04 |
Versitech Limited and R & C Biogenius Limited |
Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
|
WO2010005750A2
(en)
|
2008-06-16 |
2010-01-14 |
The Regents Of The University Of California |
Potential prognostic markers and therapeutic targets for neurological disorders
|
US20100167937A1
(en)
|
2008-07-08 |
2010-07-01 |
Power3 Medical Products, Inc. |
Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum
|
ES2595489T3
(en)
|
2008-07-18 |
2016-12-30 |
Trovagene, Inc. |
Methods for detecting "ultrashort" nucleic acid sequences based on PCR
|
WO2010011506A2
(en)
|
2008-07-23 |
2010-01-28 |
The Washington University |
Risk factors and a therapeutic target for neurodegenerative disorders
|
ES2534432T3
(en)
|
2008-07-31 |
2015-04-22 |
Queen Mary And Westfield College, University Of London |
Biomarkers of healthy kidney
|
WO2010019553A2
(en)
|
2008-08-11 |
2010-02-18 |
Banyan Biomarkers, Inc. |
Biomarker detection process and assay of neurological condition
|
ES2341419B1
(en)
|
2008-08-14 |
2011-05-03 |
Hospital Clinic I Provincial De Barcelona |
WNT1 AS RENAL DAMAGE BIOMARCATOR.
|
WO2010022210A2
(en)
|
2008-08-21 |
2010-02-25 |
Pxbiosciences Llc |
Diagnosis and monitoring of renal failure using peptide biomarkers
|
CA2735590A1
(en)
|
2008-08-29 |
2010-03-04 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2161577A1
(en)
|
2008-09-01 |
2010-03-10 |
Atlas Antibodies AB |
ANLN protein
|
CA2737379A1
(en)
|
2008-09-30 |
2010-04-08 |
Genentech, Inc. |
Biological markers predictive of rheumatoid arthritis response to lymphotoxin antagonists
|
GB0818650D0
(en)
|
2008-10-10 |
2008-11-19 |
Uni I Oslo |
Methods
|
US20100124756A1
(en)
|
2008-10-10 |
2010-05-20 |
Sandip Ray |
Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
|
WO2010048347A2
(en)
|
2008-10-21 |
2010-04-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
JP2012506537A
(en)
|
2008-10-21 |
2012-03-15 |
アスチュート メディカル,インコーポレイテッド |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2180322A1
(en)
|
2008-10-22 |
2010-04-28 |
BRAHMS Aktiengesellschaft |
Prognostic biomarkers for the progression of primary chronic kidney disease
|
KR101051435B1
(en)
|
2008-10-22 |
2011-07-22 |
한국생명공학연구원 |
Colorectal cancer diagnostic kit using colorectal cancer-related markers and colorectal cancer diagnostic method using the same
|
US20110212849A1
(en)
|
2008-10-24 |
2011-09-01 |
Vereniging VU-Windesheim; Vereniging voor Christelijk Hoger Onderwijs, |
Biomarkers for predicting the development of chronic autoimmune diseases
|
WO2010048497A1
(en)
|
2008-10-24 |
2010-04-29 |
Genizon Biosciences Inc. |
Genetic profile of the markers associated with alzheimer's disease
|
EP2352502A4
(en)
|
2008-11-06 |
2012-12-26 |
Univ Miami |
Limited proteolysis of cd2ap and progression of renal disease
|
GB2497007B
(en)
|
2008-11-07 |
2013-08-07 |
Sequenta Inc |
Methods of monitoring disease conditions by analysis of the full repertoire of the V-D junction or D-J junction sequences of an individual
|
NZ592488A
(en)
|
2008-11-10 |
2012-10-26 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2010056757A1
(en)
|
2008-11-11 |
2010-05-20 |
Entelos, Inc. |
Biomarkers for assessing atherosclerotic potential
|
US20120094295A1
(en)
|
2008-11-21 |
2012-04-19 |
The Johns Hopkins University |
Neurodegenerative disease diagnostic compositions and methods of use
|
CN103439510B
(en)
|
2008-11-22 |
2016-09-14 |
阿斯图特医药公司 |
Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
|
IT1392551B1
(en)
|
2008-11-25 |
2012-03-09 |
Bioindustry Park Del Canavese S P A |
BIOMARCERS FOR DIAGNOSIS AND TO DETECT THE PROGRESSION OF NEURODEGENERATIVE DISEASES, IN PARTICULAR OF AMIOTROPHIC LATERAL SCLEROSIS
|
NZ716924A
(en)
|
2008-12-09 |
2020-01-31 |
Stephanie Fryar Williams |
Biomarkers for the diagnosis and/or prediction of susceptibility to mental and neurodegenerative disorders
|
EP2406636B1
(en)
|
2008-12-10 |
2018-11-07 |
Joslin Diabetes Center, Inc. |
Methods of diagnosing and predicting renal disease
|
MX2013000917A
(en)
|
2010-07-23 |
2013-07-05 |
Harvard College |
Methods of detecting diseases or conditions using phagocytic cells.
|
CA2806304A1
(en)
|
2010-07-23 |
2012-01-26 |
President And Fellows Of Harvard College |
Methods of detecting prenatal or pregnancy-related diseases or conditions
|
EP2596133A4
(en)
|
2010-07-23 |
2014-04-23 |
Harvard College |
Methods of detecting neurological or neuropsychiatric diseases or conditions
|
EP2596116A4
(en)
|
2010-07-23 |
2014-03-19 |
Harvard College |
Methods of detecting autoimmune or immune-related diseases or conditions
|
EP2596349B1
(en)
|
2010-07-23 |
2017-12-13 |
President and Fellows of Harvard College |
Methods of detecting cardiovascular diseases or conditions
|
AU2011281007A1
(en)
|
2010-07-23 |
2013-02-28 |
President And Fellows Of Harvard College |
Methods of detecting kidney-associated diseases or conditions
|
BR112013001754A2
(en)
|
2010-07-23 |
2016-05-31 |
Harvard College |
method for detecting disease marks or conditions in body fluids
|
JP2014507160A
(en)
|
2011-02-22 |
2014-03-27 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス.アー.エール.エル. |
Circulating biomarker
|